该调整结果将于2023年11月30日收盘后生效。纳入及剔除名单如下:
$新诺威(SZ300765)$ $石药集团(01093)$ $MSCI明晟(MSCI)$
#价值投资# #股民的日常# #今天聊点啥#查看全文
恒瑞医药2023-10-07 20:25
近日,国际权威指数机构摩根士丹利资本国际公司(中文简称“明晟”,英文简称“MSCI”)公布最新年度环境、社会及管治(英文简称“ESG”)评级结果。恒瑞医药MSCI ESG评级连年持续提升至“A”级,在中国医药行业处于领先水平。ESG 评级稳步提升,反映出资本市场对恒瑞医药ESG管理绩效的高度认可,...查看全文
$MSCI明晟(MSCI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001408198-24-000080 Size: 5 KB 网页链接
$MSCI明晟(MSCI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001408198-24-000081 Size: 31 KB 网页链接
$MSCI明晟(MSCI)$ 8-K Current report, item 5.07 Accession Number: 0001408198-24-000077 Act: 34 Size: 199 KB 网页链接
$MSCI明晟(MSCI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001408198-24-000075 Act: 34 Size: 7 MB 网页链接
$MSCI明晟(MSCI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001408198-24-000072 Act: 34 Size: 797 KB 网页链接
$MSCI明晟(MSCI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001408198-24-000064 Size: 312 KB 网页链接
$MSCI明晟(MSCI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001408198-24-000065 Size: 4 KB 网页链接
$MSCI明晟(MSCI)$ DEF 14A Other definitive proxy statements Accession Number: 0001408198-24-000061 Act: 34 Size: 53 MB 网页链接
$MSCI明晟(MSCI)$ ARS Annual Report to Security Holders Accession Number: 0001408198-24-000059 Act: 34 Size: 23 MB 网页链接
$MSCI明晟(MSCI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001408198-24-000062 Act: 34 Size: 2 MB 网页链接